Salud financiera de hoja de balance de Orchid Pharma
Salud financiera controles de criterios 6/6
Orchid Pharma has a total shareholder equity of ₹11.7B and total debt of ₹1.4B, which brings its debt-to-equity ratio to 11.6%. Its total assets and total liabilities are ₹15.5B and ₹3.8B respectively. Orchid Pharma's EBIT is ₹872.4M making its interest coverage ratio -42.8. It has cash and short-term investments of ₹36.2M.
Información clave
11.6%
Ratio deuda-patrimonio
₹1.35b
Deuda
| Ratio de cobertura de intereses | -42.8x |
| Efectivo | ₹36.16m |
| Patrimonio | ₹11.69b |
| Total pasivo | ₹3.84b |
| Activos totales | ₹15.54b |
Actualizaciones recientes sobre salud financiera
Recent updates
Earnings Tell The Story For Orchid Pharma Limited (NSE:ORCHPHARMA) As Its Stock Soars 26%
Jul 29
We Ran A Stock Scan For Earnings Growth And Orchid Pharma (NSE:ORCHPHARMA) Passed With Ease
Jun 12Orchid Pharma Limited's (NSE:ORCHPHARMA) Intrinsic Value Is Potentially 17% Below Its Share Price
May 08Orchid Pharma Limited's (NSE:ORCHPHARMA) P/S Is Still On The Mark Following 72% Share Price Bounce
Feb 28Does Orchid Pharma (NSE:ORCHPHARMA) Have A Healthy Balance Sheet?
Feb 06Orchid Pharma Limited (NSE:ORCHPHARMA) Looks Just Right With A 33% Price Jump
Dec 18Análisis de la situación financiera
Pasivos a corto plazo: ORCHPHARMA's short term assets (₹7.9B) exceed its short term liabilities (₹2.6B).
Pasivo a largo plazo: ORCHPHARMA's short term assets (₹7.9B) exceed its long term liabilities (₹1.2B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ORCHPHARMA's net debt to equity ratio (11.3%) is considered satisfactory.
Reducción de la deuda: ORCHPHARMA had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Cobertura de la deuda: ORCHPHARMA's debt is well covered by operating cash flow (93.2%).
Cobertura de intereses: ORCHPHARMA earns more interest than it pays, so coverage of interest payments is not a concern.